Table.

PubMed citations to April 13, 2022, by arthritis diagnostic categories in early and recent decades.

Arthritis Diagnostic CategoriesPubMed
1970-79
PubMed
2013-22
Ratio of Recent to
Early Decades
PubMed
1974-2022
J Rheumatol
1974-2022a
Arthritis (all categories)26,050131,4785.1329,38511,540(3.5)
Arthritis drug trial112580977.221,1791278(6.0)
RA13,34549,7543.7142,5146537(4.6)
RA drug trial79139385.011,705826(7.1)
AS193374193.818,3101129(6.2)
AS drug trial706258.91470118(8.0)
SpA227811,7995.227,1992012(7.4)
SpA drug trial68119517.62375218(9.2)
OA335952,31315.698,8841609(1.6)
OA drug trial24020068.45312182(3.4)
SLE663531,4374.789,1292542(2.9)
SLE drug trial64128420.12951100(3.4)
Gout219680763.716,965446(2.6)
Gout drug trial816307.8112942(3.7)
Experimental arthritis (animal)767979212.821,969364(1.7)
Fibromyalgia191581530.412,672616(1.9)
MSK disorders103,912331,9903.21,017,06113,557(1.3)
  • a Numbers in parentheses are percentages of J Rheumatol citations out of total PubMed citations. J Rheumatol: The Journal of Rheumatology; AS: ankylosing spondylitis; MSK: musculoskeletal; OA: osteoarthritis; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus; SpA: spondyloarthritis.